Literature DB >> 22229022

Local Effects of Vaginally Administered Estrogen Therapy: A Review.

Megan Krause1, Thomas L Wheeler, Thomas E Snyder, Holly E Richter.   

Abstract

The results of the Women's Health Initiative (WHI) led to a distinct decline in the routine use of estrogen as preventive therapy for vasomotor symptoms, osteoporosis, and cardiovascular disease in postmenopausal women. Without estrogen replacement, one third of women experience symptoms of atrophic vaginitis including dryness, irritation, itching and or dyspareunia. Local application of estrogen has been shown to relieve these symptoms and improve quality of life for these women. In addition, local estrogen therapy may have a favorable effect on sexuality, urinary tract infections, vaginal surgery, and incontinence. This review examines the effects of vaginally applied estrogen on the vaginal epithelium, urethra and endometrium. An accompanying review examines the systemic effects of vaginally applied estrogen.

Entities:  

Year:  2009        PMID: 22229022      PMCID: PMC3252029          DOI: 10.1097/SPV.0b013e3181ab4804

Source DB:  PubMed          Journal:  J Pelvic Med Surg        ISSN: 1542-5983


  48 in total

Review 1.  The impact of hormones on menopausal sexuality: a literature review.

Authors:  Gloria A Bachmann; Sandra R Leiblum
Journal:  Menopause       Date:  2004 Jan-Feb       Impact factor: 2.953

Review 2.  The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials.

Authors:  Jeanne Leventhal Alexander; Krista Kotz; Lorraine Dennerstein; S Jerome Kutner; Kim Wallen; Morris Notelovitz
Journal:  Menopause       Date:  2004 Nov-Dec       Impact factor: 2.953

3.  Breast cancer screening among Chamorro women in southern California.

Authors:  S P Tanjasiri; L Sablan-Santos
Journal:  J Womens Health Gend Based Med       Date:  2001-06

4.  Is endometrial monitoring required with the use of long-term unopposed vaginal estrogen?

Authors:  Alastair H MacLennan; David W Sturdee
Journal:  Climacteric       Date:  2006-10       Impact factor: 3.005

5.  Hormone dynamics at the menopause.

Authors:  C Longcope
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

6.  Perimenopausal sexuality.

Authors:  W B Cutler; C R Garcia; N McCoy
Journal:  Arch Sex Behav       Date:  1987-06

7.  Estradiol absorption from vaginal tablets in postmenopausal women.

Authors:  M Notelovitz; S Funk; N Nanavati; M Mazzeo
Journal:  Obstet Gynecol       Date:  2002-04       Impact factor: 7.661

8.  Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.

Authors:  E Weisberg; R Ayton; G Darling; E Farrell; A Murkies; S O'Neill; Y Kirkegard; I S Fraser
Journal:  Climacteric       Date:  2005-03       Impact factor: 3.005

9.  Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status.

Authors:  P J Blakeman; P Hilton; J N Bulmer
Journal:  BJU Int       Date:  2000-07       Impact factor: 5.588

10.  Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.

Authors:  G A Laughlin; E Barrett-Connor; D Kritz-Silverstein; D von Mühlen
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

View more
  19 in total

1.  Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial.

Authors:  Nahid Golmakani; Aazam Parnan Emamverdikhan; Ahmadreza Zarifian; Sayyed Abolghasem Sajadi Tabassi; Malihe Hassanzadeh
Journal:  Int Urogynecol J       Date:  2018-07-03       Impact factor: 2.894

2.  Clinical Assessment of Urinary Tract Damage during Sustained-Release Estrogen Supplementation in Mice.

Authors:  Dalis E Collins; Kathleen R Mulka; Mark J Hoenerhoff; Russell S Taichman; Jason S Villano
Journal:  Comp Med       Date:  2017-02-01       Impact factor: 0.982

3.  Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.

Authors:  P Antonio Maldonado; T Ignacio Montoya; Jesus F Acevedo; Patrick W Keller; R Ann Word
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 4.  [Urethral pain syndrome: fact or fiction--an update].

Authors:  N M Dreger; S Degener; S Roth; A S Brandt; D A Lazica
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

5.  Effect of vaginal estrogen on pessary use.

Authors:  Sybil G Dessie; Katherine Armstrong; Anna M Modest; Michele R Hacker; Lekha S Hota
Journal:  Int Urogynecol J       Date:  2016-03-18       Impact factor: 2.894

Review 6.  Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants.

Authors:  Yi-Hsuan Wu; Kuang-Shun Chueh; Shu-Mien Chuang; Cheng-Yu Long; Jian-He Lu; Yung-Shun Juan
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 7.  The effects of oestrogen on vaginal wound healing: A systematic review and meta-analysis.

Authors:  Eva V Vodegel; Arnoud W Kastelein; Charlotte H J R Jansen; Jacqueline Limpens; Sandra E Zwolsman; Jan-Paul W R Roovers; Carlijn R Hooijmans; Zeliha Guler
Journal:  Neurourol Urodyn       Date:  2021-10-13       Impact factor: 2.367

8.  Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Authors:  Shahla H Al-Saqi; Kerstin Uvnäs-Moberg; Aino F Jonasson
Journal:  Post Reprod Health       Date:  2015-05-19

9.  Development of Hormonal Intravaginal Rings: Technology and Challenges.

Authors:  Fojan Rafiei; Hadi Tabesh; Shayan Farzad; Farah Farzaneh; Maryam Rezaei; Fateme Hosseinzade; Khosrow Mottaghy
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-07-13       Impact factor: 2.915

10.  Glycogen Levels in Undiluted Genital Fluid and Their Relationship to Vaginal pH, Estrogen, and Progesterone.

Authors:  Paria Mirmonsef; Anna L Hotton; Douglas Gilbert; Casey J Gioia; Danijela Maric; Thomas J Hope; Alan L Landay; Gregory T Spear
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.